AI assistant
ORAGENICS INC — Director's Dealing 2013
Dec 2, 2013
35380_dirs_2013-12-02_dc5e7d60-e537-41ee-90b2-cec5e9a2ba31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2013-11-27
Reporting Person: DUNTON ALAN W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-27 | Common Stock | A | 38397 | $0.00 | Acquired | 121063 | Direct |
Footnotes
F1: Represents a performance share award of 38,397 shares made in connection with, and as part of, the previously approved long-term compensation component of the director compensation program adopted by the Company and the award agreement with the reporting individual. The award was made under the Company?s 2012 Equity Incentive Plan (the ?Plan?) and was based upon the determination that a specified performance goal relating to a minimum aggregate capital raise in a single year had been achieved. The achievement of the award goal determination was made on November 27, 2013, and the closing price of the Company?s stock on such date was $3.00.